Skip to content
NBlaz – Lifestyle
Author:
Annovis Bio Inc.
Annovis to Participate in U.S. Biotech Day 2026 and Pharma Partnering Summit 2026
October 29, 2026
Annovis to Attend the CTAD 2026 with Three Presentations
October 22, 2026
Annovis Announces Partnership with Weave Bio, AI Regulatory Platform, in Preparation of NDA for Buntanetap in Alzheimer’s Disease
September 23, 2026
Annovis to Host Corporate Update Webinar on September 2, 2026
August 29, 2026
Annovis Provides Corporate Updates and Second Quarter 2026 Financial Results
August 14, 2026
Annovis Reaches Full Enrollment in Pivotal Phase 3 Trial of Buntanetap for Early Alzheimer’s Disease
July 7, 2026
Annovis Appoints Cheng Fang, Ph.D., as Chief Scientific Officer
July 1, 2026
Annovis Bio Regains NYSE Listing Compliance
May 26, 2026
Annovis Announces Pricing of $15.0 Million Public Offering of Common Stock and Accompanying Warrants
May 20, 2026
Annovis Announces Launch of Proposed Public Offering of Common Stock and Accompanying Warrants
May 19, 2026
1
2
Next Page
→